TY  - JOUR
T1  - Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease
AU  - Prejean, Shane
AU  - Brown, Todd M 
DO  - 10.15420/usc.2017:5:2
UR  - https://doi.org/10.15420/usc.2017:5:2
JO  - US Cardiology Review 2017;11(1):16–7
Y1  - 2017
PB  - Radcliffe Cardiology
ER  -